Viatris (VTRS) EBIT Growth (3y) (2022 - 2026)
Powered by 
Analysis
Viatris (VTRS) EBIT Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | 29.31% |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | -74.25% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -42.93% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 17.46% |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | 21.56% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 48.31% |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 2.50% |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | 33.37% |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -74.25% |
| Mar 31, 2026 | -30.05% |
| Dec 31, 2025 | 1.44% |
| Sep 30, 2025 | -31.66% |
| Jun 30, 2025 | -24.84% |
| Mar 31, 2025 | -82.46% |
| Dec 31, 2024 | -32.33% |
| Sep 30, 2024 | -14.20% |
| Jun 30, 2024 | -71.21% |
| Mar 31, 2024 | 40.37% |
| Dec 31, 2023 | 19.80% |
| Sep 30, 2023 | 59.32% |
| Jun 30, 2023 | 576.55% |
| Mar 31, 2023 | 29.36% |
| Dec 31, 2022 | -48.94% |